The effect of indole-3-carbinol on the expression of CYP1A1, CYP1B1 and AhR genes and proliferation of MCF-7 cells

Acta Biochimica Polonica

Volumn 54, Issue 1, 2007, Pages 113-117

  Ociepa Zawal, Marta ^a   Rubiś, Błazej ^a   Łaciński, Mariusz ^a   Trzeciak, Wiesław H ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

AhR; Cell proliferation; CYP; Estrone hydroxylation; p21; Xenoestrogens

Indexed keywords

EID: 33947602235     PISSN: 0001527X     EISSN: 1734154X     Source Type: Journal    
DOI: 10.18388/abp.2007_3276     Document Type: Article

References (32)

1. Angus WG, Larsen MC, Jefcoate CR (1999) Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell lines: role of estrogen receptor status. Carcinogenesis 20: 947-955.
2. Bradlow HL, Sepkovic DW, Telang NT, Osborne MP (1999) Multifunctional aspects of the action of indole-3-carbinol as an antitumor agent. Ann N Y Acad Sci 889: 204-213.
3. Brockdorff BL, Skouv J, Reiter BE, Lykkesfeldt AE (2000) Increased expression of cytochrome p450 1A1 and 1B1 genes in anti-estrogen-resistant human breast cancer cell lines. Int J Cancer 88: 902-906.
4. Bustin SA (2002) Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J Mol Endocrinol 29: 23-39.
5. Cariou S, Donovan JC, Flanagan WM, Milic A, Bhattacharya N, Slingerland JM (2000) Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells. Proc Natl Acad Sci USA 97: 9042-9046.
6. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB (1987) Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47: 936-942.
7. Chen I, McDougal A, Wang F, Safe S (1998) Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane. Carcinogenesis 19: 1631-1639.
8. Chomczynski P (1993) A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 15: 532-534, 536-537.
9. Coumoul X, Diry M, Robillot C, Barouki R (2001) Differential regulation of cytochrome P450 1A1 and 1B1 by a combination of dioxin and pesticides in the breast tumor cell line MCF-7. Cancer Res 61: 3942-3948.
10. Cover CM, Hsieh SJ, Tran SH, Hallden G, Kim GS, Bjeldanes LF, Firestone GL (1998) Indole-3-carbinol inhibits the expression of cyclin-dependent kinase-6 and induces a G1 cell cycle arrest of human breast cancer cells independent of estrogen receptor signaling. J Biol Chem 273: 3838-3847.
11. Diel P, Olff S, Schmidt S, Michna H (2002) Effects of the environmental estrogens bisphenol A, o,p′-DDT, p-tert-octylphenol and coumestrol on apoptosis induction, cell proliferation and the expression of estrogen sensitive molecular parameters in the human breast cancer cell line MCF-7. J Steroid Biochem Mol Biol 80: 61-70.
12. Firestone GL, Bjeldanes LF (2003) Indole-3-carbinol and 3-3′-diindolylmethane antiproliferative signaling pathways control cell-cycle gene transcription in human breast cancer cells by regulating promoter-Sp1 transcription factor interactions. J Nutr 133 (Suppl): 2448S-2455S.
13. Foster JS, Henley DC, Ahamed S, Wimalasena J (2001) Estrogens and cell-cycle regulation in breast cancer. Trends Endocrinol Metab 12: 320-327.
14. Hellmold H, Rylander T, Magnusson M, Reihner E, Warner M, Gustafsson JA (1998) Characterization of cytochrome P450 enzymes in human breast tissue from reduction mammaplasties. J Clin Endocrinol Metab 83: 886-895.
15. Horn TL, Reichert MA, Bliss RL, Malejka-Giganti D (2002) Modulations of P450 mRNA in liver and mammary gland and P450 activities and metabolism of estrogen in liver by treatment of rats with indole-3-carbinol. Biochem Pharmacol 64: 393-404.
16. Iscan M, Klaavuniemi T, Coban T, Kapucuoglu N, Pelkonen O, Raunio H (2001) The expression of cytochrome P450 enzymes in human breast tumours and normal breast tissue. Breast Cancer Res Treat 70: 47-54.
17. Jaga K, Brosius D (1999) Pesticide exposure: human cancers on the horizon. Rev Environ Health 14: 39-50.
18. Jefcoate CR, Liehr JG, Santen RJ, Sutter TR, Yager JD, Yue W, Santner SJ, Tekmal R, Demers L, Pauley R, Naftolin F, Mor G et al. (2000) Tissue-specific synthesis and oxidative metabolism of estrogens. J Natl Cancer Inst Monogr 27: 95-112.
19. Jellinck PH, Forkert PG, Okey AB, Michnovicz JJ, Bradlow HL (1993) Ah receptor binding properties of indole carbinols and induction of hepatic estradiol hydroxylation. Biochem Pharmacol 45: 1129-1136.
20. Lai A, Sarcevic B, Chu W, Jernstrom H, Narod SA (2001) Insulin/insulin-like growth factor-I and estrogen cooperate to stimulate cyclin E-Cdk2 activation and cell cycle progression in MCF-7 breast cancer cells through differential regulation of cyclin E and p21(WAF1/Cip1). J Biol Chem 276: 25823-25833.
21. Lee AJ, Cai MX, Thomas PE, Conney AH, Zhu BT (2003) Characterization of the oxidative metabolites of 17β-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms. Endocrinology 144: 3382-3398.
22. Leibelt DA, Hedstrom OR, Fischer KA, Pereira CB, Williams DE (2003) Evaluation of chronic dietary exposure to indole-3-carbinol and absorption-enhanced 3,3′-diindolylmethane in Sprague-Dawley rats. Toxicol Sci 74: 10-21.
23. Li Y, Li X, Sarkar FH (2003) Gene expression profiles of I3C- and DIM-treated PC3 human prostate cancer cells determined by cDNA microarray analysis. J Nutr 133: 1011-1019.
24. Liu H, Wormke M, Safe SH, Bjeldanes LF (1994) Indolo[3,2-b]carbazole: a dietary-derived factor that exhibits both antiestrogenic and estrogenic activity. J Natl Cancer Inst 86: 1758-1765.
25. Michnovicz JJ, Bradlow HL (1990) Induction of estradiol metabolism by dietary indole-3-carbinol in humans. J Natl Cancer Inst 82: 947-949.
26. Safe S (2001) Molecular biology of the Ah receptor and its role in carcinogenesis. Toxicol Lett 120: 1-7.
27. Sanders R (1998) Chalk up another for broccoli! Chemical in vegetable shown to halt growth of breast cancer. News Release: [www.berkeley.edu/news/ media/releases/98legacy/02_20_98a.html].
28. Sanderson JT, Slobbe L, Lansbergen GW, Safe S, van den Berg M (2001) 2,3,7,8-Tetrachlorodibenzo-p-dioxin and diindolylmethanes differentially induce cytochrome P450 1A1, 1B1, and 19 in H295R human adrenocortical carcinoma cells. Toxicol Sci 61: 40-48.
29. Sonnenschein C, Soto AM, Fernandez MF, Olea N, Olea-Serrano MF, Ruiz-Lopez MD (1995) Development of a marker of estrogenic exposure in human serum. Clin Chem 41: 1888-1895.
30. Spink DC, Spink BC, Cao JQ, DePasquale JA, Pentecost BT, Fasco MJ, Li Y, Sutter TR (1998) Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells. Carcinogenesis 19: 291-298.
31. Tiwari R, Guo KL, Bradlow HL, Telang NT, Osborne MP (1994) Selective responsiveness of human breast cancer cells to indole-3-carbinol, a chemopreventive agent. J Natl Cancer Inst 86: 126-131.
32. Zava DT, Blen M, Duwe G (1997) Estrogenic activity of natural and synthetic estrogens in human breast cancer cells in culture. Environ Health Perspect 105 (Suppl 3): 637-645.